The National Distinguished Advocacy Award


Nomination Procedure

Nominations must be submitted no later than Monday, July 8, 2024. 

A biography and formal rationale must be submitted with each nomination. 

An ACS CAN volunteer-led awards workgroup will review nominations and select the award winners from among the nominees in accordance with the nomination criteria. 

Appropriate personnel will be notified after the award winners have been selected. The award will be presented at an ACS CAN event or at another time of significance to ACS CAN or the recipient as appropriate.

Please contact [email protected] with questions.

Award Purpose

The National Distinguished Advocacy Award (NDAA) is the highest national advocacy honor bestowed by the American Cancer Society Cancer Action Network (ACS CAN) and is the mark of distinction and accomplishment in the field of public policy advocacy pertaining to cancer.

Nomination Criteria

Nominees for the NDAA are individuals (including lawmakers or public officials) or organizations that have demonstrated support of the Society and ACS CAN's shared mission through impactful leadership or significant advocacy on a state or national level.




Information on the Nominee:

Nomination Rationale:

Using the questions below, please explain the rationale for the nomination:

  1. In 500 words or less, describe the nominee's role in cancer advocacy and the impact of the nominee's contribution to cancer advocacy.
  2. Describe the nominee's connection to cancer in addition to his/her advocacy efforts.
  3. Drawing from the award information guidelines listed in this form, please list specific cancer advocacy accomplishments.

Your Contact Information